Related references
Note: Only part of the references are listed.Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
Hannah G. Rosenblum et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Prevalence of High-Risk Nonvaccine Human Papillomavirus Types in Advanced Squamous Cell Carcinoma Among Individuals of African vs Non-African Ancestry
Erik A. Williams et al.
JAMA NETWORK OPEN (2021)
Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States
Kayla Saadeh et al.
VACCINE (2020)
Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
Filipe Colaco Mariz et al.
NPJ VACCINES (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
Andreas Ahrlund-Richter et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women
Andrew F. Brouwer et al.
BMC PUBLIC HEALTH (2019)
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Melanie Drolet et al.
LANCET (2019)
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination
Lauri E. Markowitz et al.
VACCINE (2019)
Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey
Nancy M. McClung et al.
JOURNAL OF ADOLESCENT HEALTH (2019)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018
Tanja Y. Walker et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Human Papillomavirus-Attributable Cancers - United States, 2012-2016
Virginia Senkomago et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction
Courtney Covert et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection
Monica Saccucci et al.
SEXUALLY TRANSMITTED DISEASES (2018)
Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program
Suzanne M. Garland et al.
VACCINE (2018)
Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S
Jacqueline Hirth et al.
VACCINE (2018)
Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis
M. Canvin et al.
SEXUALLY TRANSMITTED INFECTIONS (2017)
Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014
Sara E. Oliver et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction
Lili Ding et al.
VACCINE (2017)
Prevalence of HPV After Introduction of the Vaccination Program in the United States
Lauri E. Markowitz et al.
PEDIATRICS (2016)
Human Papillomavirus Vaccination and Cervical Cytology Outcomes Among Urban Low-Income Minority Females
Annika M. Hofstetter et al.
JAMA PEDIATRICS (2016)
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
David Mesher et al.
EMERGING INFECTIOUS DISEASES (2016)
Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013
Eileen F. Dunne et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012
Mahbubur Rahman et al.
VACCINE (2015)
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2014
Sarah Reagan-Steiner et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2015)
Evaluation of Human Papillomavirus Type Replacement Postvaccination Must Account for Diagnostic Artifacts: Masking of HPV52 by HPV16 in Anogenital Specimens
Joseph E. Tota et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Monitoring Effect of Human Papillomavirus,Vaccines in US Population, Emerging Infections Program, 2008-2012
Susan Hariri et al.
EMERGING INFECTIOUS DISEASES (2015)
Burden of Cervical, Anal, and Oral HPV in an Inner-City Pre-vaccine Adolescent Population
Nicolas F. Schlecht et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2013)
Significant Decrease in the Incidence of Genital Warts in Young Danish Women After Implementation of a National Human Papillomavirus Vaccination Program
Louise Baandrup et al.
SEXUALLY TRANSMITTED DISEASES (2013)
Occurrence of vaccine and non-vaccine human papillomavirus types in adolescent Finnish females 4 years post-vaccination
Johanna Palmroth et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
Talia Malagon et al.
LANCET INFECTIOUS DISEASES (2012)
Cervical, Anal and Oral HPV in an Adolescent Inner-City Health Clinic Providing Free Vaccinations
Nicolas F. Schlecht et al.
PLOS ONE (2012)
Prevalence of Genital Human Papillomavirus Among Females in the United States, the National Health and Nutrition Examination Survey, 2003-2006
Susan Hariri et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Nubia Munoz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality
Melinda Butsch Kovacic et al.
CANCER RESEARCH (2006)
Long-term outcome of chronic drug use - The Amsterdam Cohort Study among Drug Users
F Termorshuizen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Against which human papillomavirus types shall we vaccinate and screen?: The international perspective
N Muñoz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
